San Diego, CA, United States of America

John Charles Arthur

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Charles Arthur. Retrieved from https://idiyas.com/inventor/john-charles-arthur-r5j9okia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Charles Arthur and Oligonucleotide Purification

Introduction

John Charles Arthur is an inventor associated with San Diego, California, and Isis Pharmaceuticals, Inc. His patent work concerns methods for purifying oligonucleotides.

Latest Patents

Arthur is named on one patent: “Processes of Purifying Oligonucleotides.” The invention describes treating a solution containing an oligonucleotide with an aggregating agent and a precipitation enhancer under conditions that form an oligonucleotide aggregate, then isolating that aggregate to obtain a purified oligonucleotide. His listed patent count is 1 patent.

Career Highlights

Arthur’s recorded invention addresses the preparation of purified oligonucleotides, compounds used in biotechnology and molecular research. The available information associates his work with Isis Pharmaceuticals, Inc.

Collaborations

Arthur’s listed coworkers include Max N. Moore and Anthony Scozzari. Their names provide context for the professional network associated with his patent record.

Conclusion

John Charles Arthur’s patent focuses on an aggregation-and-isolation process for purifying oligonucleotides, reflecting his documented contribution to biotechnology-related innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…